Pharma Companies Urge U.S. To Intervene As India Aims To Issue Compulsory Licenses For Some Drugs
Reuters: Big Pharma pushes for U.S. action against India over patent worries
“Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said…” (Chatterjee/Hirschler, 2/6).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.